<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>MYA Space | Lloyd Cervantes | Activity</title>
	<link>https://space.mya.co.uk/members/harbormoat3/activity/</link>
	<atom:link href="https://space.mya.co.uk/members/harbormoat3/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lloyd Cervantes.</description>
	<lastBuildDate>Sat, 19 Sep 2026 22:29:19 +0100</lastBuildDate>
	<generator>https://buddypress.org/?v=10.2.0</generator>
	<language>en-GB</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">8c412013fa4b40bab0fc40de7c8a02dd</guid>
				<title>Lloyd Cervantes posted an update: The risk to have a VKC affected person affected by Chemical [&#133;]</title>
				<link>https://space.mya.co.uk/activity/p/1653041/</link>
				<pubDate>Mon, 16 Oct 2023 08:10:14 +0100</pubDate>

									<content:encoded><![CDATA[<p>The risk to have a VKC affected person affected by Chemical To explain current treatments involving ocular phlegm membrane layer pemphigoid (OMMP), such as traditional wide spread immunosuppression (CIST) and fresh biologics brokers. CIST continues to be the primary continue to be treatments to the control over OMMP. Selecting providers will be&hellip;<span class="activity-read-more" id="activity-read-more-1653041"><a href="https://space.mya.co.uk/activity/p/1653041/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">978918ea6d0562369ef04f6cce7cde65</guid>
				<title>Lloyd Cervantes posted an update: When compared to the KH class, following your treatment [&#133;]</title>
				<link>https://space.mya.co.uk/activity/p/1639888/</link>
				<pubDate>Sun, 15 Oct 2023 10:29:01 +0100</pubDate>

									<content:encoded><![CDATA[<p>When compared to the KH class, following your treatment period, patients from the ADH party had higher initialized partial thromboplastin period (aPTT) (12, [95% self confidence period [CI] Half a dozen.97, 19.August), p =  much less next <a href="https://www.selleckchem.com/products/Maraviroc.html" rel="nofollow ugc">selleck inhibitor</a> 0.10), worldwide stabilized rate (INR) (Zero.18, [95% CI 0.&#8217;07, 0.28), p =  much less th&hellip;<span class="activity-read-more" id="activity-read-more-1639888"><a href="https://space.mya.co.uk/activity/p/1639888/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">cabb0bab9e33135340b661523a1e5dc1</guid>
				<title>Lloyd Cervantes became a registered member</title>
				<link>https://space.mya.co.uk/activity/p/1639675/</link>
				<pubDate>Sun, 15 Oct 2023 10:14:54 +0100</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>
<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/

Object Caching 0/128 objects using Redis
Page Caching using Disk: Enhanced 
Lazy Loading
Database Caching using Redis (Request-wide modification query)

Served from: space.mya.co.uk @ 2026-09-20 02:03:25 by W3 Total Cache
-->